Advertisement
Canada markets closed
  • S&P/TSX

    22,167.03
    +59.95 (+0.27%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CAD/USD

    0.7383
    -0.0004 (-0.05%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • Bitcoin CAD

    95,175.68
    -710.04 (-0.74%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • RUSSELL 2000

    2,124.55
    +10.20 (+0.48%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • NASDAQ

    16,379.46
    -20.06 (-0.12%)
     
  • VOLATILITY

    13.01
    0.00 (0.00%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     
  • CAD/EUR

    0.6836
    -0.0007 (-0.10%)
     

Stocks in play: Aleafia Health Inc.

Reported its financial results for the 2019 fourth quarter and fiscal year. First quarterly positive adjusted EBITDA of $0.2M in Q4 2019. 27% increase in Q4 2019 net cannabis revenue over the previous quarter. 1,748% increase in FY 2019 net cannabis revenue over the previous year. Gross margin on cannabis net revenue of 80% in Q4 2019. Q4 2019 SG&A expenses of $4.3 million, a decrease of 11% over previous quarter. $41.2M cash and cash equivalents at December 31, 2019. Aleafia Health Inc. shares T.ALEF are trading down $0.115 at $0.35.

Read: